Skip to content
Insider tapeFilings through Fri, Oct 9
Watchlist
BNGO

Bionano Genomics (BNGO) stock: insider trades, news & valuation

Health Care · Quiet
Close · Oct 9, 2026 $1.44 -1.4% on the day -32.4% over 12 months 52-week range $1.06 – $2.13

Share price and insider trades

BNGO closeInsider buyInsider sale
1.001.502.002.50NovDecJan 2026FebMarAprMayJunJulAugSepOctBought $4,840 on 2026-09-04 · Albert LudererBought $4,880 on 2026-08-21 · Albert Luderer
Bought, 12 months$0
Sold, 12 months$0
Insiders buying0
Insiders selling0

Bionano Genomics insider trading at a glance (Oct 9, 2026): in the past 12 months, 0 insiders bought $0 and 0 sold $0 of BNGO stock on the open market.

BNGO insider buying and selling by quarter

Open-market purchases (green, above the line) and sales (red, below), by trade date.

Q3 2026: $10K bought (2 trades)$10KQ3 2026Q4 2026
QuarterBoughtPurchasesSoldSales
Q4 2026—0—0
Q3 2026$10K2—0

Valuation, profit and volume

P/E (trailing)n/aSector median 24.7
Market value$16.9MMedical Instruments & Supplies
Profit margin-106.6%Revenue growth +21.4%
Volume vs. 50-day0.2×Last 5 sessions
Insiders' paper profit+$2KOn all tracked purchases +18.5%

Summary

No open-market purchases or sales by Bionano Genomics, Inc. insiders were reported in the past 12 months.

BNGO stock news and SEC filings

Recent 8-K filings and headlines. Tone is scored from the headline wording; “Policy” marks regulatory, trade or government topics.

Insider transactions

Open-market purchases and sales.

Filed Insider Type Shares Price Value Since Score
Sep 9SEC Albert LudererCEO Buy 4,0008,000 held (+100%) $1.21 $5K +19.0% —
Aug 21SEC Albert LudererCEO Buy 4,000new position $1.22 $5K +18.0% —

Insiders at Bionano Genomics, Inc.

InsiderBoughtSoldLast filingScore
Albert LudererCEO $10K — Sep 9, 2026 —

Insider activity at other Health Care companies

Same sector, ranked by insider buying in the last 90 days.

  • SLBTSL Science Holding Ltd$10329.90B bought
  • KODKodiak Sciences Inc.$157M bought
  • ADRXADARx Pharmaceuticals, Inc.$87.7M bought
  • ATTOAttovia Therapeutics, Inc.$72.9M bought
  • MPLTMapLight Therapeutics, Inc.$65.5M bought
  • AVRAnteris Technologies Global Corp.$40.4M bought

BNGO stock: common questions

Are Bionano Genomics, Inc. insiders buying BNGO stock?

In the past 12 months, 0 insiders reported open-market purchases of BNGO worth $0. The latest was CEO Albert Luderer bought $5K of BNGO at $1.21 — raises the stake by 100%.

Are Bionano Genomics, Inc. insiders selling BNGO stock?

0 insiders reported sales worth $0 over the same period.

Where does this data come from?

Every transaction comes from Form 4 filings that insiders must submit to the SEC within two business days of a trade. We pull them from SEC EDGAR every night.

What is BNGO's 52-week range?

Over the past year BNGO has traded between $1.06 and $2.13. It last closed at $1.44 on Oct 9, 2026.